Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are critical for blood vessel formation (angiogenesis).
• Angiogenesis is fundamental to physiological and pathological processes, involving endothelial cell proliferation, migration, survival, and vessel formation.
• The VEGF/VEGFR-2 system precisely mediates the signaling cascades involved in angiogenesis.

Purpose of the Study:

• To elucidate the molecular mechanisms of VEGF/VEGFR-2 signaling in angiogenesis.
• To explore the potential of VEGFR-2-targeted therapies for VEGF/VEGFR-2-associated diseases.

Main Methods:

• Analysis of VEGF binding to VEGFR-2 domains (IgD2, IgD3).
• Investigation of receptor dimerization, tyrosine kinase activation, and autophosphorylation.
• Identification of key phosphorylated sites (Tyr801, Tyr951, Tyr1175, Tyr1214) and associated intracellular signaling pathways (e.g., PLCγ-PKC, TSAd-Src-PI3K-Akt).

Main Results:

• VEGF binding to VEGFR-2 initiates dimerization, kinase activation, and intracellular signaling.
• Specific phosphorylated sites on VEGFR-2 mediate critical signaling cascades.
• These pathways regulate endothelial cell proliferation, migration, and survival, crucial for angiogenesis.

Conclusions:

• The VEGF/VEGFR-2 signaling pathway is a central regulator of angiogenesis.
• Targeting strategies include blocking the pathway, inhibiting gene expression, preventing ligand-receptor binding, and inhibiting endothelial cell functions.
• VEGFR-2-targeted therapies hold potential for treating diseases associated with aberrant VEGF/VEGFR-2 signaling.